Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa Concentrate in Patients With Acquired Haemophilia and in Patients With Haemophilia A With Inhibitors
This section is Not applicable
Observational Model: Cohort, Time Perspective: Prospective
Assessment of patient's individual response to therapy with by-passing agents by simultaneous use of TGA and TEM methods.
This is non-inverventional study as the protocol will not assign specific treatment to the particular subjects of the study. Patients will be treated with APCC or rFVIIa based on the experience of the study site. Patients are prescribed a treatment according to their physician's judgement or local clinical practice. This is observation of the everyday clinical practise on site.
Maria Podolak-Dawidziak, MD, PhD
Blood Neoplasms and Bone Marrow Transplantation of the Wroclaw Medical University
Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products